10.2741/2787 64 HawleyS
The next section splits these mechanisms into two practical groups: FDA-approved GLP-1 drugs available only by prescription, such as semaglutide and tirzepatide, and non-prescription peptides that work through growth-hormone stimulation or fat-cell targeting instead, such as CJC-1295 and AOD-9604
Metabolic Benefits Retatrutide significantly improves insulin sensitivity, blood sugar, cholesterol, and liver fat
On 21 May 2026 , Lilly published the long-awaited topline results from the TRIUMPH-1 Phase 3 trial, and the data is striking: participants on the highest dose lost an average of 28.3% of their body weight at 80 weeks , with 45.3% of patients losing 30% or more a threshold previously only achievable with bariatric surgery
You should only take semaglutide for diabetes if you have been prescribed it by a doctor
The question that actually matters is not which form is better in the abstract